Glycogen synthase kinase-3: a key kinase in retinal neuron apoptosis in early diabetic retinopathy

被引:13
|
作者
Li Zhaohui [1 ]
Ma Ling [2 ]
Chen Xiaodong [1 ]
Li Yonghao [1 ]
Li Shiyi [1 ]
Zhang Jinglin [1 ]
Lu Lin [1 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
关键词
retinal neuron; apoptosis; lithium chloride; glycogen synthase kinase-3; diabetic retinopathy; mitochondrial dysfunction; GANGLION-CELL LINE; SURVIVAL; DEATH; RATS; NEUROPROTECTION; GSK3-BETA; INSULIN; LITHIUM;
D O I
10.3760/cma.j.issn.0366-6999.20141347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diabetes-related pathogenic factors can cause retinal ganglion cell (RGC) apoptosis, but the specific mechanism is not very clear. The aim of this study is to investigate the correlation between glycogen synthase kinase-3 (GSK-3) activation and retinal neuron apoptosis. Methods In an in vitro experiment, the number of apoptotic RGC-5 cells differentiated by staurosporine was evaluated via flow cytometry and nuclei staining using Hoechst 33258. GSK-3 phosphorylation and caspase-3 activation in RGC-5 cells after serum deprivation were determined using Western blotting. Mitochondrial membrane potential was detected using the dye 5,5',6,6'-tetrachloro-1,1',3,3'-tetrethyl benzimidalyl carbocyanine iodide, and reactive oxygen species (ROS) levels were measured with dihydroethidium. In an in vivo experiment, the number of apoptotic retinal neurons was evaluated via terminal transferase dUTP nick-end labeling (TUNEL), and GSK-3 phosphorylation was determined using Western blotting, in the retinal nerve epithelial tissue of rats in which diabetes was induced by intravenous tail-vein injection of streptozotocin for 4 weeks. Results The levels of phosphorylated Ser21/9 in GSK-3 alpha/beta and p-T308/S473-AKT were lower and the cleaved caspase-3 levels were higher in the serum-deprived model (P <0.05). Lithium chloride treatment was associated with a slower rate of apoptosis, increased mitochondrial membrane potential, and decreased ROS levels in differentiated RGC-5 cells (P <0.05). The level of blood glucose and the number of TUNEL-positive cells in the whole-mounted retinas were higher (P <0.01), and the levels of phosphorylated Ser21/9 in GSK-3 alpha/beta and body weight were lower (P <0.05). However, the thickness of the retinal nerve epithelial layer was not significantly less in diabetic rats compared with control group. Lithium chloride intravitreal injection increased the levels of phosphorylated Ser21/9 in GSK-3 alpha/beta and decreased TUNEL-positive cells in the whole-mounted retinas. Conclusion GSK-3 kinase is closely related to retinal neuron apoptosis, and the application of the GSK-3 inhibitor lithium chloride can reduce retinal neuron apoptosis in early diabetic retinopathy.
引用
收藏
页码:3464 / 3470
页数:7
相关论文
共 50 条
  • [21] The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil
    Jing Xu
    Pengjuan Xu
    Zhigui Li
    Lu Xiao
    Zhuo Yang
    Cellular & Molecular Biology Letters, 2013, 18 : 494 - 506
  • [22] Glycogen synthase kinase-3β regulation: another kinase gets in on the AKT
    Turk, Benjamin E.
    FEBS LETTERS, 2018, 592 (04): : 535 - 536
  • [23] Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice
    King, Matthew R.
    Anderson, Nicholas J.
    Guernsey, Lucie S.
    Jolivalt, Corinne G.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2013, 91 (04) : 506 - 514
  • [24] The neuron-specific isoform of glycogen synthase kinase-3β is required for axon growth
    Castano, Zafira
    Gordon-Weeks, Phillip R.
    Kypta, Robert M.
    JOURNAL OF NEUROCHEMISTRY, 2010, 113 (01) : 117 - 130
  • [25] The primary defect in glycogen synthase activity is not based on increased glycogen synthase kinase-3α activity in diabetic myotubes
    Gaster, M
    Brusgaard, K
    Handberg, A
    Hojlund, K
    Wojtaszewski, JFP
    Beck-Nielsen, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (04) : 1235 - 1240
  • [26] Blind docking of manzamines into glycogen synthase kinase-3β
    Sivaprakasam, P.
    Hamann, M.
    Doerksen, R. J.
    PLANTA MEDICA, 2008, 74 (03) : 335 - 335
  • [27] INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY POLYCATIONS
    HEGAZY, MG
    SCHLENDER, KK
    WILSON, SE
    REIMANN, EM
    FASEB JOURNAL, 1988, 2 (04): : A596 - A596
  • [28] QSAR modeling of the inhibition of Glycogen Synthase Kinase-3
    Katritzky, Alan R.
    Pacureanu, Liliana M.
    Dobchev, Dimitar A.
    Fara, Dan C.
    Duchowicz, Pablo R.
    Karelson, Mati
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (14) : 4987 - 5002
  • [29] Glycogen synthase kinase-3 a negative regulator of hypertrophy
    Haq, SE
    Choukroun, G
    Lee, KH
    Ranu, H
    Vayssier-Taussat, M
    Boecker, W
    Woodgett, J
    Molkentin, JD
    Michael, A
    Force, T
    CIRCULATION, 2000, 102 (18) : 140 - 140
  • [30] Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection
    Li, XH
    Bijur, GN
    Jope, RS
    BIPOLAR DISORDERS, 2002, 4 (02) : 137 - 144